EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Active Glycogen Synthase in the Liver Prevents High-Fat Diet-Induced Glucose Intolerance, Decreases Food Intake, and Lowers Body Weight

Iliana López-Soldado, Joan J Guinovart, Jordi Duran iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Iliana López-Soldado und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. Hauptthemen laut MEDLINE: Glucose Intolerance, Liver Glycogen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: La Marató de TV3, Spanish Ministry of Science, Spanish Ministry of Science, Innovation, and Universities (MCIU/FEDER/AEI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many lines of evidence demonstrate a correlation between liver glycogen content and food intake. We previously demonstrated that mice overexpressing protein targeting to glycogen (PTG) specifically in the liver—which have increased glycogen content in this organ—are protected from high-fat diet (HFD)-induced obesity by reduced food intake. However, the use of PTG to increase liver glycogen implies certain limitations. PTG stimulates glycogen synthesis but also inhibits the enzyme responsible for glycogen degradation. Furthermore, as PTG is a regulatory subunit of protein phosphatase 1 (PP1), which regulates many cellular functions, its overexpression could have side effects beyond the regulation of glycogen metabolism. Therefore, it is necessary to determine whether the direct activation of glycogen synthesis, without affecting its degradation or other cellular functions, has the same effects. To this end, we generated mice overexpressing a non-inactivatable form of glycogen synthase (GS) specifically in the liver (9A-MGSAlb mice). Control and 9a-MGSAlb mice were fed a standard diet (SD) or HFD for 16 weeks. Glucose tolerance and feeding behavior were analyzed. 9A-MGSAlb mice showed an increase in hepatic glycogen in fed and fasting conditions. When fed an HFD, these animals preserved their hepatic energy state, had a reduced food intake, and presented a lower body weight and fat mass than control animals, without changes in energy expenditure. Furthermore, 9A-MGSAlb animals showed improved glucose tolerance when fed an SD or HFD. Moreover, liver triacylglycerol levels that were increased after HFD feeding were lower in these mice. These results confirm that increased liver glycogen stores contribute to decreased appetite and improve glucose tolerance in mice fed an HFD. On the basis of our findings, strategies to preserve hepatic glycogen stores emerge as potential treatments for obesity and hyperglycemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucose IntoleranceLiver GlycogenAnimalsMiceBody WeightDiet, High-FatEatingGlucoseGlycogen SynthaseLiverMice, Inbred C57BLObesity

Stichwörter der Autor:innen

ATPfood intakeglucoseglycogenglycogen synthasehigh-fat dietliver

Substanzen

GlucoseGlycogen SynthaseLiver Glycogen

Autor:innen und Institutionen

  • Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
  • Department of Biochemistry and Molecular Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
  • Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), 08017 Barcelona, Spain.
  • Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain.

ORCID-Profile: Jordi Duran

Förderung

  • La Marató de TV3
  • Spanish Ministry of Science
  • Spanish Ministry of Science, Innovation, and Universities (MCIU/FEDER/AEI)
  • CIBER de Diabetes y Enfermedades Metabólicas Asociadas (ISCIII, Ministerio de Ciencia e Innovación), and “La Marató de TV3” Foundation

Zitieren

APA

López-Soldado, I., Guinovart, J. J., & Duran, J. (2023). Active Glycogen Synthase in the Liver Prevents High-Fat Diet-Induced Glucose Intolerance, Decreases Food Intake, and Lowers Body Weight. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032574

Vancouver

López-Soldado I, Guinovart JJ, Duran J. Active Glycogen Synthase in the Liver Prevents High-Fat Diet-Induced Glucose Intolerance, Decreases Food Intake, and Lowers Body Weight. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032574

BibTeX
@article{LpezSoldado2023,
  author = {López-Soldado, Iliana and Guinovart, Joan J and Duran, Jordi},
  title = {Active Glycogen Synthase in the Liver Prevents High-Fat Diet-Induced Glucose Intolerance, Decreases Food Intake, and Lowers Body Weight},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032574}
}
Kostenlos starten →